Oxford Nanopore Technologies

Oxford Nanopore Technologies, established in 2005, is a specialized manufacturer operating within the test and measurement equipment industry. The firm focuses on the development and production of advanced nanopore sequencing technology, creating sophisticated electronic, single-molecule sensing systems designed for complex scientific and medical applications. Their proprietary platform facilitates rapid, real-time DNA and RNA analysis, establishing the company as a critical player in the global biotechnology sector.

Currently, the organization operates with 1,000-5,000 employees across 11 international locations, supported by a robust research and development program. Their comprehensive product portfolio features the MinION, GridION, PromethION, and Flongle devices, which deliver highly portable and accessible sequencing solutions for diverse research environments. Meet Oxford Nanopore Technologies's team to learn more about the leadership and technical experts driving these significant technological advancements in molecular sensing.

Backed by an extensive intellectual property portfolio, Oxford Nanopore Technologies continues to expand its operational footprint in healthcare and biotechnology markets. The company is publicly traded on the London Stock Exchange under the ticker LON: ONT and recently reported annual revenue of $215.0M. Explore financial highlights to gain deeper insights into their market performance, strategic growth, and historical funding rounds, which include substantial capital from global investors to support their ongoing innovation in high-quality, scalable sequencing technology.